Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans
Reducing Prostate Cancer Disparities Among African Americans
2 other identifiers
interventional
6
1 country
1
Brief Summary
This trial studies how well a lifestyle intervention works in reducing prostate cancer disparities among African American prostate cancer patients and their spouses or romantic partners. A lifestyle intervention may help researchers learn if social support can help African American prostate cancer patients and their partners improve their quality of life, support from their partner, physical activity, diet, and inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 27, 2019
CompletedFirst Submitted
Initial submission to the registry
November 26, 2019
CompletedFirst Posted
Study publicly available on registry
January 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
April 15, 2026
April 1, 2026
6.9 years
November 26, 2019
April 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Implementing a lifestyle intervention and active surveillance on couple-based behavioral intervention developed for African American (AA) or Hispanic men
We will calculate rates of recruitment and retention, along with 90% confidence intervals (CIs). Participant feedback will be summarized using means and standard deviations (SDs)
up to 6 months
Study Arms (3)
Group I (exercise plan, coaching calls, nutrition counseling)
EXPERIMENTALPatients and their partners receive an exercise plan and printed materials that includes instructions for walking or other moderate-intensity activities. Patients and their partners also receive coaching calls discussing physical activity and diet related questions, each lasting 45-60 minutes and occurring every 2 weeks for 6 months. In addition, patients and their partners complete 2 nutrition counseling sessions over 1 hour each at baseline and before month 3 with an MD Anderson registered dietitian.
Group II (physical activity/healthy eating information)
ACTIVE COMPARATORPatients and their partners receive information/materials regarding physical activity and healthy eating.
Provider Interviews (interviews)
EXPERIMENTALHealthcare providers participate in an interview regarding their opinions on family-focused care and its ability to improve health behaviors.
Interventions
Receive exercise plan
Receive printed exercise materials
Complete nutrition counseling sessions
Ancillary studies
Receive coaching calls
Eligibility Criteria
You may qualify if:
- To be eligible, prostate cancer survivors must self-identify as black or African American
- Prostate cancer survivors must have 0-III stage prostate cancer
- Prostate cancer survivors must have completed therapy (e.g., surgery, chemotherapy \[chemo\] and/or radiation)
- Prostate cancer survivors must enroll with a spouse or a romantic partner
- Prostate cancer survivors must not meet physical activity recommendation (i.e., 150 minutes of moderate intensity physical activity per week)
- Prostate cancer survivors must be willing and able to be physically active, as determined by responses to the Physical Activity Readiness Questionnaire (PAR-Q)
- Prostate cancer survivors must not participate in another physical activity, diet, or lifestyle program
- Prostate cancer survivors must have a valid home address and telephone number
- Prostate cancer survivors must be able to access internet over a smartphone or a computer at home or other location (e.g., work, church, library, community center, etc.)
- To be eligible, spouses or romantic partners must be \>=18 years of age
- Spouses or romantic partners must enroll with a spouse or a romantic partner with prostate cancer
- Spouses or romantic partners must live together with the survivors
- Spouses or romantic partners must not have major health problems (e.g., cancer, dementia, stroke, and heart and lung diseases)
- Spouses or romantic partners must be willing and able to be physically active, as determined by responses to the Physical Activity Readiness Questionnaire (PAR-Q)
- To be eligible, healthcare providers must be currently providing care with individuals diagnosed with prostate cancer
- +1 more criteria
You may not qualify if:
- Prostate cancer survivors will be excluded if they are not married or partnered
- Prostate cancer survivors will be excluded if they have an active noncutaneous malignancy at any site
- Prostate cancer survivors will be excluded if they had a prior history of other cancer or have metastatic cancer
- Prostate cancer survivors will be excluded if they have planned concomitant immunotherapy, hormonal therapy, chemotherapy, or radiation therapy during the study period
- Prostate cancer survivors will be excluded if they are on active surveillance
- Prostate cancer survivors will be excluded if they enrolled in a protocol #: 2017-0556
- Prostate cancer survivors will be excluded if they are not able to understand and speak English
- Spouses or romantic partners who are not able to understand and speak English will be excluded
- Also, spouses or romantic partners who enrolled in a protocol (#2017-0556) will be excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- Brander Beacons Cancer Researchcollaborator
- National Cancer Institute (NCI)collaborator
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dalnim Cho
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2019
First Posted
January 2, 2020
Study Start
August 27, 2019
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
April 15, 2026
Record last verified: 2026-04